Gilead Sciences laid off 108 employees at Arcellx's Redwood City headquarters after closing $7.8B acquisition on April 28, 2026; layoffs effective June 30.
Additional 192 jobs to be cut at former Arcellx facilities in Rockville.
Arcellx had 220 employees as of March 1, 2026; cuts nearly halve workforce with $3.3M in severance costs.
BioNTech plant closures to eliminate 1,860 jobs, listed in 2026 Layoff Tracker.
Acquisition terms:
$115/share cash + $5/share CVR, total ~$7.8B equity value.